| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/06/1998 | EP0839054A1 Tumor- or cell-specific herpes simplex virus replication |
| 05/06/1998 | EP0838999A2 Insect control with multiple toxins |
| 05/06/1998 | CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family |
| 05/05/1998 | US5747324 Plasmid vectors for insertion in dna for pox virus vectors, prokarotic origin and dna sequences |
| 05/05/1998 | US5747323 Dna fragment which promotes encapsulation of retroviral vectors |
| 05/05/1998 | US5747307 Mason-Pfizer Monkey Retroviral packaging defective vectors |
| 04/30/1998 | WO1998017817A1 Retroviral vectors |
| 04/30/1998 | WO1998017816A1 Lentiviral vectors |
| 04/30/1998 | WO1998017815A1 Retroviral vectors |
| 04/30/1998 | WO1998017799A1 Immunotherapy and improved vaccines |
| 04/30/1998 | WO1998017786A1 Heat inactivation of viruses in antibody preparations |
| 04/30/1998 | WO1998017783A1 Improved adenovirus vectors |
| 04/30/1998 | DE19644500A1 AAV-DNA mit Helfervirus-Sequenzen AAV DNA having helper virus sequences |
| 04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2745736A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2269074A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2268271A1 Lentiviral vectors |
| 04/30/1998 | CA2267636A1 Retroviral vectors |
| 04/30/1998 | CA2240843A1 Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same |
| 04/29/1998 | EP0837929A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 04/29/1998 | EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 04/29/1998 | CN1180377A Human embryonic lung fibroblast diploid cell strain suitable for production of virus and process for production of varicella zoster virus using same |
| 04/29/1998 | CN1180376A Cell line and process for multiplying rabies viruses and their quantitative detection |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |
| 04/28/1998 | US5744141 Flavivirus recombinant poxvirus immunological composition |
| 04/28/1998 | US5744140 Recombinant poxvirus containing forein dna from encephalitis virus protein m or virus protein e, ns1, and ns2a |
| 04/28/1998 | US5744133 Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0836648A1 Recombinant mva virus, and the use thereof |
| 04/22/1998 | EP0836484A1 In vitro packaging of adeno-associated virus dna |
| 04/22/1998 | EP0836481A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
| 04/21/1998 | US5741696 Recombinant equine herpesviruses |
| 04/21/1998 | US5741683 Transduction of mammal cells and gene therapy |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/21/1998 | CA1339829C Produit of interferon from human genes |
| 04/16/1998 | WO1998015637A1 Herpes simplex virus strains |
| 04/16/1998 | WO1998015636A1 Alphavirus-retrovirus vectors |
| 04/16/1998 | CA2268353A1 Alphavirus-retrovirus vectors |
| 04/16/1998 | CA2255939A1 Herpes simplex virus strains |
| 04/15/1998 | EP0835930A1 European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV) |
| 04/15/1998 | EP0835929A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 04/15/1998 | EP0835321A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 04/15/1998 | EP0835320A1 Improved retroviral vectors, especially suitable for gene therapy |
| 04/15/1998 | EP0835315A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/15/1998 | EP0835137A1 Encapsulated cells producing viral particles |
| 04/15/1998 | EP0835133A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 04/15/1998 | EP0835132A1 Novel recombinant temperature sensitive mutants of influenza |
| 04/15/1998 | EP0835131A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86 |
| 04/14/1998 | US5739026 DNA expression systems based on alphaviruses |
| 04/14/1998 | US5739019 Method of isolating and propagating microorganisms and viruses |
| 04/09/1998 | WO1998014578A1 Biological insect control agents expressing insect-specific mite toxin genes, methods and compositions |
| 04/09/1998 | WO1998014564A1 Synthetic hpv16 virus-like particles |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/08/1998 | EP0833934A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/08/1998 | EP0833923A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 04/08/1998 | EP0833903A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 04/08/1998 | EP0833896A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833661A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/07/1998 | US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736388 Genetic engineering |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736328 Hybridization assays for detecting the presence of an AIDS-associated virus |
| 04/07/1998 | US5736319 Analyzing for absence of glycoproteins x or i in pseudorabies virus antigen-containing serum of animals (i.e. swine) to distinguish between vaccination and virulent infections |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736294 Genetic engineering |
| 04/02/1998 | WO1998013511A1 Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic togavirus vectors |
| 04/02/1998 | WO1998013510A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | WO1998013501A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013487A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013485A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2268265A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2266855A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | CA2266423A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | CA2265554A1 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/01/1998 | EP0832267A1 Adenovirus vectors for gene therapy |
| 04/01/1998 | EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 04/01/1998 | EP0832202A1 Aav directed targeted integration |
| 04/01/1998 | EP0832197A1 Recombinant fowlpox viruses and uses thereof |
| 04/01/1998 | EP0831922A2 Improved pharmaceutical compositions for gene therapy |
| 04/01/1998 | EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
| 04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease |
| 03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/26/1998 | WO1998012341A1 Kshv positive cell lines |
| 03/26/1998 | WO1998012339A2 Viral vectors and their uses |
| 03/26/1998 | WO1998012314A1 Retroviral vectors capable of transducing non-dividing cells |
| 03/26/1998 | WO1998011916A1 Viral defective interfering particles and uses thereof |
| 03/26/1998 | WO1998006827A3 Method for immortalizing cells |